A holistic assessment of the sources, prevalence, and distribution of bisphenol A and analogues in water, sediments, biota and plastic litter of the Ebro Delta (Spain)

Autor: R. Gil-Solsona, J.M. Castaño-Ortiz, R. Muñoz-Mas, S. Insa, M. Farré, N. Ospina-Alvarez, L.H.M.L.M. Santos, M. García-Pimentel, D. Barceló, S. Rodríguez-Mozaz

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
© Environmental Pollution, 2022, vol. 314, art. núm. 120310
Articles publicats (ICRA)
DUGiDocs – Universitat de Girona

Bisphenol A (BPA) is one of the main ubiquitous compounds released from plastics in the environment. This compound, considered an endocrine disruptor, poses a risk to aquatic wildlife and human population, being included in multiple environmental mon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9392e5c2c2cdfed1d0cad55e0d61f002
https://pubmed.ncbi.nlm.nih.gov/36206893

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

Autor: Peters, S. Stahel, R.A. Dafni, U. Ponce Aix, S. Massutí, B. Gautschi, O. Coate, L. López Martín, A. van Heemst, R. Berghmans, T. Meldgaard, P. Cobo Dols, M. Garde Noguera, J. Curioni-Fontecedro, A. Rauch, D. Mark, M.T. Cuffe, S. Biesma, B. van Henten, A.M.J. Juan Vidal, Ó. Palmero Sanchez, R. Villa Guzmán, J.C. Collado Martin, R. Peralta, S. Insa, A. Summers, Y. Láng, I. Horgan, A. Ciardiello, F. de Hosson, S. Pieterman, R. Groen, H.J.M. van den Berg, P.M. Zielinski, C.C. Chittazhathu Kurian Kuruvilla, Y. Gasca-Ruchti, A. Kassapian, M. Novello, S. Torri, V. Tsourti, Z. Gregorc, V. Smit, E.F. EMPHASIS-lung Collaborative Group

Introduction Docetaxel and erlotinib are registered second-line treatments for wild-type EGFR NSCLC. Previous studies suggested a predictive value of the VeriStrat test in second-line therapy of NSCLC, classifying patients as either VeriStrat good or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0ba1507d0ad73b0dfce28aff8c071fdd
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108791

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Enzyme mediated degradation of hormones and EDCs in wastewater – a novel biotechnological approach

Autor: D Becker, S Rodriguez-Mozaz, M Llorca, S Insa, D Barceló, M De Cazes, J Sanchez, M P Belleville, R Schoevaart, O Couillerot, J De Gunzburg, J Oehlmann, M Wagner

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::904b25b44ce0a817ef79dd8b58ba20d2